Olgu Sunumu
Yıl 2019,
Cilt: 1 Sayı: 2, 53 - 56, 01.12.2019
Öz
Kaynakça
- REFERENCES:[1] Laurie SA, Ho AL, Fury MG, et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 2011;12:815–24.[2] Chaudhry AP, Leifer C, Cutler LS, et al. Histogenesis of adenoid cystic carcinoma of the salivary glands. Light and electronmicroscopic study. Cancer 1986;58:72–82.[3] Canyilmaz E, Uslu GH, Memıs¸ Y, et al. Adenoid cystic carcinoma of the breast: a case report and literature review. Oncol Lett 2014;7:1599–601.[4] Eriko T, Tadahiro S, Miura J, et al. Chemoradiotherapy with irinotecan (CPT-11) for adenoid cystic carcinoma of Bartholin’sgland: a case report and review of the literature. Gynecol Oncol Rep. 2013;4:16–9.[5] Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary origin.Aclinicopathologic study of242 cases.AmJ Surg1974;128:512–20.[6] Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007Surveillance, Epidemiology, and End Results data. Cancer 2012;118: 4444–51.[7] Finan MA, Barre G. Bartholin’s gland carcinoma, malignant melanoma and other rare tumours of the vulva. Best Pract Res Clin Obstet Gynaecol 2003;17:609e33.[8] Chamlian DL, Taylor HB. Primary carcinoma of Bartholin’s gland. A report of 24 patients. Obstet Gynecol 1972;39:489e94.[9] Copeland LJ, Sneige N, Gershenson DM, Saul PB, Stringer CA, Seski JC. Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol1986;67:115e20.[10] Bernstein SG, Voet RL, Lifshitz S, Buchsbaum HJ. Adenoid cystic carcinoma of Bartholin’s gland. Case report and review of the literature. Am J Obstet Gynecol 1983;147:385e90.[11] Lelle RJ, Davis KP, Roberts JA. Adenoid cystic carcinoma of the Bartholin’s gland: The University of Michigan experience. Int J Gynecol Cancer 1994;4:145e9.[12] Yang SY, Lee JW, Kim WS, Jung KL, Lee SJ, Lee JH, et al. Adenoid cystic carcinoma of the Bartholin’s gland: report of two cases and review of the literature. Gynecol Oncol 2006;100:422e5.[13]. Rosenberg P, Simonsen E, Risberg B. Adenoid cystic carcinoma of Bartholin’s gland: a report of five new cases treated with surgery and radiotherapy. Gynecol Oncol. 1989;34:145–7.[14]. Copeland LJ, Sneige N, Gershenson DM, Saul PB, Stringer CA, Seski JC. Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol. 1986;67(1):115–20.[15]. Alsan CI, Vinh-Hung V, Eren F, Abacioğlu U. Adenoid cystic carcinoma of theBartholin’s gland: case report and systematic review of the literature. Eur JGynaecol Oncol. 2011;32(5):567–72.
Yıl 2019,
Cilt: 1 Sayı: 2, 53 - 56, 01.12.2019
Öz
The adenoid cystic carcinoma (ACC) of the Bartholin’s gland (BG) is one of the most
uncommon variant of vulvar malignancies representing only 10–15% of cases. Risk
factors to the development of ACCBG are still unclear. The symptoms are usually
non-specific .
In the present study, we present a 61-year-old woman with a vulvar mass evolving
since 4 years, without pruritus or pains, without other signs. She initially benefited of
an excisional biopsy of the mass returning in favour of a nodular hidradenoma. The
evolution after 1 year was marked by the recurrence of the mass, the patient had an
ablation of the masse then a total vulvectomy and bilateral lymph node dissection
because pathology showed ACC of Bartholin’s gland with positif surgical margins.
She received adjuvant external beam radiation to the pelvis and on the operating
bed. Patient’s evolution was marked by complete remission maintained after 4years
follow-up.
Conclusion : Adenoid cystic carcinoma of vulva is an extremely rare, slowly
progressing neoplasm mostly involving the Bartholin’s gland. The usual treatment
includes wide excision and adjuvant radiotherapy (if required). There may be late
local and distant recurrence.
Anahtar Kelimeler
adenoid cystic carcinoma bartholin's gland surgery radiotherapy chemotherapy surhical margins
Kaynakça
- REFERENCES:[1] Laurie SA, Ho AL, Fury MG, et al. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncol 2011;12:815–24.[2] Chaudhry AP, Leifer C, Cutler LS, et al. Histogenesis of adenoid cystic carcinoma of the salivary glands. Light and electronmicroscopic study. Cancer 1986;58:72–82.[3] Canyilmaz E, Uslu GH, Memıs¸ Y, et al. Adenoid cystic carcinoma of the breast: a case report and literature review. Oncol Lett 2014;7:1599–601.[4] Eriko T, Tadahiro S, Miura J, et al. Chemoradiotherapy with irinotecan (CPT-11) for adenoid cystic carcinoma of Bartholin’sgland: a case report and review of the literature. Gynecol Oncol Rep. 2013;4:16–9.[5] Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary origin.Aclinicopathologic study of242 cases.AmJ Surg1974;128:512–20.[6] Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007Surveillance, Epidemiology, and End Results data. Cancer 2012;118: 4444–51.[7] Finan MA, Barre G. Bartholin’s gland carcinoma, malignant melanoma and other rare tumours of the vulva. Best Pract Res Clin Obstet Gynaecol 2003;17:609e33.[8] Chamlian DL, Taylor HB. Primary carcinoma of Bartholin’s gland. A report of 24 patients. Obstet Gynecol 1972;39:489e94.[9] Copeland LJ, Sneige N, Gershenson DM, Saul PB, Stringer CA, Seski JC. Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol1986;67:115e20.[10] Bernstein SG, Voet RL, Lifshitz S, Buchsbaum HJ. Adenoid cystic carcinoma of Bartholin’s gland. Case report and review of the literature. Am J Obstet Gynecol 1983;147:385e90.[11] Lelle RJ, Davis KP, Roberts JA. Adenoid cystic carcinoma of the Bartholin’s gland: The University of Michigan experience. Int J Gynecol Cancer 1994;4:145e9.[12] Yang SY, Lee JW, Kim WS, Jung KL, Lee SJ, Lee JH, et al. Adenoid cystic carcinoma of the Bartholin’s gland: report of two cases and review of the literature. Gynecol Oncol 2006;100:422e5.[13]. Rosenberg P, Simonsen E, Risberg B. Adenoid cystic carcinoma of Bartholin’s gland: a report of five new cases treated with surgery and radiotherapy. Gynecol Oncol. 1989;34:145–7.[14]. Copeland LJ, Sneige N, Gershenson DM, Saul PB, Stringer CA, Seski JC. Adenoid cystic carcinoma of Bartholin gland. Obstet Gynecol. 1986;67(1):115–20.[15]. Alsan CI, Vinh-Hung V, Eren F, Abacioğlu U. Adenoid cystic carcinoma of theBartholin’s gland: case report and systematic review of the literature. Eur JGynaecol Oncol. 2011;32(5):567–72.
Toplam 1 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | İç Hastalıkları |
| Bölüm | Vaka Takdimi |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Aralık 2019 |
| Kabul Tarihi | 3 Ekim 2019 |
| Yayımlandığı Sayı | Yıl 2019 Cilt: 1 Sayı: 2 |
Chief Editors
Assoc. Prof. Zülal Öner
İzmir Bakırçay University, Department of Anatomy, İzmir, Türkiye
Assoc. Prof. Deniz Şenol
Düzce University, Department of Anatomy, Düzce, Türkiye
Editors
Assoc. Prof. Serkan Öner
İzmir Bakırçay University, Department of Radiology, İzmir, Türkiye
E-mail: medrecsjournal@gmail.com
Publisher:
Medical Records Association (Tıbbi Kayıtlar Derneği)
Address: Orhangazi Neighborhood, 440th Street,
Green Life Complex, Block B, Floor 3, No. 69
Düzce, Türkiye
Web: www.tibbikayitlar.org.tr
Publication Support:
Effect Publishing & Agency
Phone: + 90 (553) 610 67 80
E-mail: info@effectpublishing.com
Address: Şehit Kubilay Neighborhood, 1690 Street,
No:13/22, Ankara, Türkiye
web: www.effectpublishing.com